LATAM BD signs commercial agreement with Peritech Pharma
Herzliya, Israel, February 20, 2018 – Peritech Pharma, a specialty anal-rectal pharmaceutical company, today announced the first commercial agreement for two of its over-the-counter products, PP-110 for hemorrhoids and PP-120 for anal itching. The deal, signed with Latam BD Group, includes local manufacturing and marketing in Brazil and 23 other countries in Central and South America, and the Caribbean. Peritech is also in advanced negotiations for licensing its products in additional territories around the world.
“We are delighted to partner with experienced and savvy teams in Latin America and the Caribbean,” said Peritech Founder and CEO Eran Eilat, MD, PhD.
“We are very optimistic that PP-110 and PP-120 will help patients suffering from hemorrhoids in light of the top-notch clinical results showing reduction in discomfort for patients,” added Latam BD Group partner Mr. Avi Meizler.